Chymase Inhibition Reduces Infarction and Matrix Metalloproteinase-9 Activation and Attenuates Inflammation and Fibrosis after Acute Myocardial Ischemia/Reperfusion

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.111.179697PMID 21795433PMCID PMC11047277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Guide for the Care and Use of Laboratory Animals (8th edn)

  2012cited by this paper
• Effects of interleukin-18 on cardiac fibroblast function and gene expression.

  2011cited by this paper
• Leupeptin preserves cardiac nitric oxide synthase 3 during reperfusion following long-term cardioplegia.

  2010cited by this paper
• Mast cell proteases: multifaceted regulators of inflammatory disease.

  2010cited by this paper
• Effect of Thrombin Fragment (TP508) on Myocardial Ischemia Reperfusion Injury in a Model of Type 1 Diabetes Mellitus

  2010cited by this paper
• Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin–angiotensin system

  2010cited by this paper
• The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis

  2010cited by this paper
• IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction

  2009cited by this paper
• Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis.

  2009cited by this paper
• The intracellular renin-angiotensin system in the heart

  2009cited by this paper
• Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs.

  2009cited by this paper
• Endothelial nitric oxide (NO) and its pathophysiologic regulation.

  2008cited by this paper
• Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

  2008cited by this paper
• Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.

  2007cited by this paper
• sICAM-1 measurements are independent of processing method and sampling site in patients with coronary artery disease

  2007cited by this paper
• A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*

  2005cited by this paper
• Evidence for altered interleukin (IL)‐18 pathway in human heart failure

  2004cited by this paper
• A Novel Chymase Inhibitor, 4-[1-{[bis-(4-Methyl-phenyl)-methyl]-carbamoyl}-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), Suppressed Cardiac Fibrosis in Cardiomyopathic Hamsters

  2003cited by this paper
• Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction.

  2003cited by this paper
• Identification of a stable chymase inhibitor using a pharmacophore-Based database search.

  2003cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

  2000influential reference
• Interactions of angiotensin-converting enzyme, kinins and nitric oxide in circulation and the beneficial effects of ACE inhibitors in cardiovascular diseases.

  2000cited by this paper
• Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

  1999cited by this paper
• Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.

  1999cited by this paper
• Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy.

  1998cited by this paper
• Chymase cleavage of stem cell factor yields a bioactive, soluble product.

  1997cited by this paper
• Dog Mast Cell α-Chymase Activates Progelatinase B by Cleaving the Phe88-Gln89 and Phe91-Glu92 Bonds of the Catalytic Domain*

  1997cited by this paper
• Cleavage of Type I Procollagen by Human Mast Cell Chymase Initiates Collagen Fibril Formation and Generates a Unique Carboxyl-terminal Propeptide*

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase.

  1996cited by this paper

• Chymase and Fetuin-A in Metabolic Inflammation: Molecular Pathways Linking to Insulin Resistance

  2026cites this paper
• Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis.

  2025cites this paper
• Targeting inhibition of the inflammatory response: advances in the treatment of myocardial fibrosis with natural medicine and active ingredients

  2025cites this paper
• N-terminal domain of CTRP9 promotes cardiac fibroblast activation in myocardial infarction via Rap1/Mek/Erk pathway

  2025cites this paper
• Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle

  2024cites this paper
• Cardiac fibrogenesis: an immuno-metabolic perspective

  2024cites this paper
• Mast cells: a novel therapeutic avenue for cardiovascular diseases?

  2024cites this paper
• Tryptase and Exogenous Trypsin: Mechanisms and Ophthalmic Applications

  2023cites this paper
• Is chymase 1 a therapeutic target in cardiovascular disease?

  2023cites this paper
• Impact of early pericardial fluid chymase activation after cardiac surgery

  2023cites this paper
• Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9

  2022cites this paper
• MED1 Deficiency in Macrophage Aggravates Isoproterenol Induced Cardiac Fibrosis in Mice.

  2022cites this paper
• Effects of Neonatal Administration of Non-Opiate Analogues of Leu-Enkephalin to Heart Tissue Homeostasis of Prepubertal Albino Rats Exposed to Hypoxia

  2022cites this paper
• Commentary: If it looks too good to be true, it probably is

  2021cites this paper
• Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury

  2021cites this paper
• Effects of Angiotensin Converting Enzyme 2 and Angiotensin Converting Enzyme Genes on Cardiac Remodeling in Rats with Heart Failure

  2021cites this paper
• The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

  2021cites this paper
• Histamine receptors in heart failure

  2021cites this paper
• Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors

  2020cites this paper
• A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation

  2020cites this paper
• Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide)

  2020cites this paper
• Japanese encephalitis virus neuropenetrance is driven by mast cell chymase

  2019cites this paper
• Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.

  2019cites this paper
• Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease

  2019cites this paper
• Increase of chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes after acute myocardial infarction chymase activity after acute myocardial infarction

  2019cites this paper
• Regulation of Type 2 Immunity in Myocardial Infarction

  2019cites this paper
• Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury

  2019cites this paper
• Modulation of connective tissue growth factor and activin receptor 2b function in cardiac hypertrophy and fibrosis

  2019cites this paper
• Sex differences in gene expression in response to ischemia in the human left ventricular myocardium.

  2019cites this paper
• Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury

  2018cites this paper
• Sex differences in gene expression in response to ischemia in the human myocardium

  2018cites this paper
• Mast Cells: Key Contributors to Cardiac Fibrosis

  2018cites this paper
• Propofol attenuates myocardial ischemia reperfusion injury partly through inhibition of resident cardiac mast cell activation

  2018influential citation
• Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis

  2018cites this paper
• Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

  2018cites this paper
• The controversial role of mast cells in fibrosis

  2018cites this paper
• Therapeutic targeting of cathepsin C: from pathophysiology to treatment

  2018cites this paper
• Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction

  2018cites this paper
• Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)

  2018cites this paper
• A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction

  2018cites this paper
• Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr192 and compromises its cardioprotective activity[S]

  2018influential citation
• Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.

  2017cites this paper
• The effect of dietary curcumin on hepatic chymase activity and serum fetuin‐A levels in rats fed on a high‐fat diet

  2017cites this paper
• Effect of Age, Estrogen Status, and Late-Life GPER Activation on Cardiac Structure and Function in the Fischer344×Brown Norway Female Rat

  2017cites this paper
• The mast cell demystified: A novel target for anti-inflammatory strategies after circulatory arrest?

  2017cites this paper
• Immune cells in repair of the infarcted myocardium

  2017cites this paper
• Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury

  2017cites this paper
• Mesenchymal stem cells and vascular regeneration

  2017cites this paper
• Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice.

  2017cites this paper
• Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure

  2017cites this paper
• Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench

  2016cites this paper
• Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.

  2016cites this paper
• Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis

  2016cites this paper
• Suppression of Conjunctival Scarring by Chymase Inhibitor in a Canine Symblepharon Model

  2016cites this paper
• Improvement of cardiovascular remodelling by chymase inhibitor

  2016cites this paper
• IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction

  2016cites this paper
• The impact of mast cells on cardiovascular diseases.

  2016cites this paper
• "Fibroblast" pharmacotherapy - Advancing the next generation of therapeutics for clinical cardiology.

  2016cites this paper
• Systemic mastocytosis presenting as cardiac tamponade with CD25+ pericardial mast cells

  2016cites this paper
• Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease

  2016cites this paper
• Confocal laser scanning microscope, Raman microscopy and Western blotting to evaluate inflammatory response after myocardial infarction.

  2015cites this paper
• Mast Cells Play an Important Role in Chlamydia pneumoniae Lung Infection by Facilitating Immune Cell Recruitment into the Airway

  2015cites this paper
• Approaches for analyzing the roles of mast cells and their proteases in vivo.

  2015cites this paper
• The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

  2015cites this paper
• Mast Cells and HDL : Studies on Cholesterol Efflux and Reverse Cholesterol Transport

  2015cites this paper
• Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy

  2014cites this paper
• Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats

  2014cites this paper
• Chymase Mediates Injury and Mitochondrial Damage in Cardiomyocytes during Acute Ischemia/Reperfusion in the Dog

  2014cites this paper
• The role of mast cells in ischemia and reperfusion injury

  2014cites this paper
• Investigational drugs targeting cardiac fibrosis

  2014cites this paper
• Mast cell degranulation promotes ischemia-reperfusion injury in rat liver.

  2014cites this paper
• Proteases as Clinical Markers of Adverse Remodeling for Heart Failure in the Aging Population

  2014cites this paper
• Haematopoietic Serine Proteases : A Cleavage Specificity Analysis

  2014cites this paper
• Chymase mediated intestinal epithelial permeability is regulated by protease activating 1

  2013cites this paper
• Role of Chymase in Matrix and Myocardial Remodeling Due to Mitral Regurgitation: Implications for Therapy

  2013cites this paper
• Chymase inhibitors.

  2013cites this paper
• Role of chymase in preeclampsia.

  2013cites this paper
• Discovery of potent, selective chymase inhibitors via fragment linking strategies.

  2013cites this paper
• Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

  2013cites this paper
• Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?

  2013cites this paper
• Characterization of the Cardiac Renin Angiotensin System in Oophorectomized and Estrogen-Replete mRen2.Lewis Rats

  2013cites this paper
• Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation

  2013influential citation
• Lentivirus-mediated RNA interference of chymase increases the plaque stability in atherosclerosis in vivo.

  2013cites this paper
• Salvianolic Acid A, a Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling in Spontaneously Hypertensive Rats

  2013cites this paper
• A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis.

  2012cites this paper
• Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters.

  2012cites this paper
• Multiple mechanisms for the action of chymase inhibitors.

  2012cites this paper
• Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells

  2012cites this paper
• Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes.

  2012cites this paper
• Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?

  2012influential citation
• Becker Digital

  year unknowncites this paper
• Cellular and Molecular Life Sciences the Pathogenesis of Cardiac Fibrosis

  year unknowncites this paper